// App-Quantinova.ai

TCT-31 : Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Researchers

Presenter

  • Seung Hun Lee

Principal Investigators

  • Ki Hong Choi

  • Joo Myung Lee

  • Taek Kyu Park

  • Jeong Hoon Yang

  • Joo-Yong Hahn

  • Young Joon Hong

  • Ju Han Kim

  • Byeong-Keuk Kim

  • Hyung Joon Joo

  • Kiyuk Chang

  • Yongwhi Park

  • Sung Gyun Ahn

  • Jung-Won Suh

  • Sang Yeub Lee

  • Jung Rae Cho

  • Ae-Young Her

  • Young-Hoon Jeong

  • Hyo-Soo Kim

  • Moo Hyun Kim

  • Do-Sun Lim

  • Eun-Seok Shin

  • Youngkeun Ahn

  • Seung-Hyuck Choi

  • Hyeon-Cheol Gwon

  • Myung Ho Jeong

  • Young Bin Song

Medical Centers

  • Seoul National University Hospital, Seoul, Korea

  • Kangwon National University, Chuncheon, Korea

  • Yonsei University Cardiovascular Hospital, Seoul, Korea

  • Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

  • Samsung Medical Center, Seoul, Korea

  • Yonsei University Wonju College of Medicine, Wonju, Korea

  • Dong-A University Hospital, Busan, Korea

  • Gyeongsang National University Changwon Hospital, Changwon, Korea

  • Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea

  • Cardiology Division, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea

Locations

  • Republic of South Korea

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A